rs760079073
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_144997.7(FLCN):c.1199T>C(p.Val400Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,682 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V400F) has been classified as Uncertain significance.
Frequency
Consequence
NM_144997.7 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLCN | ENST00000285071.9 | c.1199T>C | p.Val400Ala | missense_variant | Exon 11 of 14 | 1 | NM_144997.7 | ENSP00000285071.4 | ||
| ENSG00000264187 | ENST00000427497.3 | n.*33T>C | non_coding_transcript_exon_variant | Exon 7 of 12 | 1 | ENSP00000394249.3 | ||||
| ENSG00000264187 | ENST00000427497.3 | n.*33T>C | 3_prime_UTR_variant | Exon 7 of 12 | 1 | ENSP00000394249.3 | ||||
| MPRIP | ENST00000578209.5 | c.*18-1009A>G | intron_variant | Intron 5 of 5 | 3 | ENSP00000464276.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000201 AC: 5AN: 249156 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461598Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 727104 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74296 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Birt-Hogg-Dube syndrome Uncertain:2
- -
This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 400 of the FLCN protein (p.Val400Ala). This variant is present in population databases (rs760079073, gnomAD 0.004%). This missense change has been observed in individual(s) with breast cancer (PMID: 36315513). ClinVar contains an entry for this variant (Variation ID: 565465). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FLCN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Birt-Hogg-Dube syndrome 1 Benign:1
This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at